Biotechnology Stocks by Market Cap
This screen lists companies classified under the Biotechnology industry in Finnhub sector data, sorted by market cap descending. Biotech names often carry pipeline and regulatory event risk; market cap rank is one dimension of a much wider research process.
Data as of Oct 20, 2026 (weekly refresh)
Showing 50 companies · sorted by Market Cap (highest first)
| Ticker | Company | Industry | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBVIE INC | Biotechnology | $285.42 | $504.37B | 79.9 | 3.6% | 10.4% | 67.6% | 72.8% | 5.7% | 49.22 | 24.9% | ||
| Amgen Inc | Biotechnology | $426.65 | $233.82B | 26.7 | 4.6% | 9.1% | 31.7% | 74.3% | 13.3% | 4.90 | 32.1% | ||
| Gilead Sciences, Inc | Biotechnology | $154.90 | $193.67B | — | 6.6% | 5.5% | — | 79.6% | -8.5% | 2.22 | 27.3% | ||
| VERTEX PHARMACEUTICALS INC | Biotechnology | $499.74 | $126.66B | 28.8 | 3.0% | 10.2% | 22.5% | 86.0% | 23.3% | 0.00 | 10.2% | ||
| MODERNA INC | Biotechnology | $218.01 | $87.04B | — | 1.0% | -27.6% | — | 36.4% | -37.0% | 0.09 | 639.3% | ||
| Regeneron Pharmaceuticals Inc | Biotechnology | $790.74 | $81.41B | 18.8 | 4.4% | 9.3% | 1.9% | 86.0% | 12.7% | 0.09 | 2.4% | ||
| Natera Inc | Biotechnology | $393.44 | $56.71B | — | 0.1% | 37.8% | — | 65.2% | -11.2% | 0.04 | 71.7% | ||
| argenx SE | Biotechnology | $819.14 | $53.61B | 21.7 | 1.5% | 165.2% | 95.7% | 89.8% | 22.3% | 0.01 | 1.5% | ||
| BeOne Medicines AG | Biotechnology | $369.06 | $42.12B | 63.0 | 5.7% | 31.1% | — | 88.5% | 10.7% | 0.22 | -4.7% | ||
| Revolution Medicines Inc | Biotechnology | $177.96 | $38.14B | — | — | — | — | — | -47.0% | 0.40 | 123.4% | ||
| Biogen Inc | Biotechnology | $233.48 | $34.37B | 41.2 | 7.4% | 0.3% | -46.0% | 74.0% | 3.3% | 0.43 | 32.2% | ||
| Alnylam Pharmaceuticals Inc | Biotechnology | $233.29 | $31.22B | 38.4 | 2.6% | 95.1% | — | 79.7% | 22.9% | 2.02 | -41.7% | ||
| Roivant Sciences Ltd | Biotechnology | $34.30 | $24.22B | — | — | -67.6% | — | 81.2% | -6.1% | 0.00 | 54.5% | ||
| INCYTE CORP | Biotechnology | $113.07 | $22.92B | 14.2 | 8.4% | 26.9% | 80.3% | 93.1% | 29.4% | 0.01 | 14.5% | ||
| United Therapeutics Corp | Biotechnology | $543.15 | $22.87B | 17.4 | 4.8% | 2.5% | 9.1% | 86.1% | 20.2% | 0.00 | 9.4% | ||
| Genmab A/S | Biotechnology | $37.00 | $22.72B | 28.8 | 3.8% | 22.3% | -36.4% | 93.0% | 8.0% | 0.89 | 23.4% | ||
| Biontech SE | Biotechnology | $89.21 | $22.03B | — | 5.6% | -11.8% | — | 79.2% | -9.0% | 0.02 | -7.9% | ||
| Insmed Inc | Biotechnology | $95.70 | $21.02B | — | — | 185.8% | — | 83.5% | -57.8% | 0.96 | -44.7% | ||
| Exelixis Inc | Biotechnology | $62.23 | $15.42B | 17.9 | 7.6% | 9.2% | 52.7% | 96.5% | 42.5% | 0.00 | 42.0% | ||
| Ascendis Pharma A/S | Biotechnology | $229.95 | $14.34B | 16.9 | 2.8% | 113.3% | — | 91.3% | 51.1% | 0.31 | 5.6% | ||
| HALOZYME THERAPEUTICS INC | Biotechnology | $121.84 | $13.83B | 33.4 | 4.3% | 41.1% | -23.5% | 82.4% | 18.7% | 14.95 | 81.0% | ||
| Neurocrine Biosciences Inc | Biotechnology | $136.98 | $13.79B | 19.6 | 6.3% | 34.4% | 101.3% | 98.0% | 21.1% | 0.00 | -4.3% | ||
| BridgeBio Pharma Inc | Biotechnology | $68.03 | $12.98B | — | — | 202.4% | — | 94.4% | -65.3% | 8.27 | -13.2% | ||
| Summit Therapeutics Inc | Biotechnology | $15.57 | $12.45B | — | — | — | — | — | -168.9% | 0.00 | -16.4% | ||
| BioMarin Pharmaceutical Inc | Biotechnology | $54.68 | $10.58B | 145.1 | 6.9% | 11.2% | -89.2% | 79.6% | 0.9% | 0.66 | -8.0% | ||
| Madrigal Pharmaceuticals Inc | Biotechnology | $449.74 | $10.39B | — | 0.9% | 149.0% | — | 91.5% | -35.6% | 0.65 | -22.8% | ||
| Vaxcyte Inc | Biotechnology | $63.62 | $10.01B | — | — | — | — | — | -37.6% | 0.00 | 37.9% | ||
| Krystal Biotech Inc | Biotechnology | $319.53 | $9.37B | 38.8 | 2.8% | 22.6% | 62.4% | 94.6% | 19.3% | 0.00 | 28.4% | ||
| Kymera Therapeutics Inc | Biotechnology | $108.07 | $8.99B | — | — | 134.8% | — | — | -21.4% | 0.00 | 34.7% | ||
| Immunitybio Inc | Biotechnology | $8.42 | $8.92B | — | — | 192.9% | — | 99.3% | -193.0% | 0.00 | 363.6% | ||
| Twist Bioscience Corp | Biotechnology | $132.75 | $8.74B | — | — | 19.2% | — | 52.0% | -29.9% | 0.00 | 318.5% | ||
| Protagonist Therapeutics Inc | Biotechnology | $134.44 | $8.70B | 104.0 | 2.5% | 34.8% | 46.0% | — | 12.0% | 0.00 | 47.4% | ||
| Caris Life Sciences Inc | Biotechnology | $30.86 | $8.64B | 82.1 | 1.4% | 38.5% | — | 69.7% | 11.2% | 0.66 | 13.3% | ||
| Cytokinetics Inc | Biotechnology | $62.75 | $8.61B | — | 0.7% | -21.1% | — | — | -18.7% | 6.01 | -2.5% | ||
| TG Therapeutics Inc | Biotechnology | $53.30 | $8.16B | 18.7 | 0.7% | 76.1% | 633.7% | 82.4% | 39.9% | 1.23 | 81.0% | ||
| ABIVAX SA-ADR | Biotechnology | $88.13 | $8.06B | — | — | — | — | — | -107.5% | 0.00 | -34.4% | ||
| ARROWHEAD PHARMACEUTICALS IN | Biotechnology | $55.90 | $7.90B | — | 1.3% | 16.9% | — | — | -21.9% | 2.70 | -15.8% | ||
| Ionis Pharmaceuticals Inc | Biotechnology | $44.38 | $7.38B | — | 7.5% | -7.5% | — | 98.2% | -21.8% | 4.35 | -45.7% | ||
| SPYRE THERAPEUTICS INC | Biotechnology | $79.90 | $7.37B | — | — | — | — | — | -24.3% | 0.00 | 143.9% | ||
| Alkermes Plc | Biotechnology | $43.55 | $6.92B | 104.6 | 5.7% | 10.8% | -81.6% | 84.6% | 2.6% | 0.83 | 47.3% | ||
| Praxis Precision Medicines Inc | Biotechnology | $257.85 | $6.75B | — | — | — | — | — | -43.0% | 0.00 | -18.0% | ||
| Grifols SA | Biotechnology | $7.59 | $6.72B | 13.2 | 10.7% | -0.3% | 52.7% | 37.0% | 3.1% | 1.59 | -4.9% | ||
| Iovance Biotherapeutics Inc | Biotechnology | $14.21 | $6.44B | — | — | 34.5% | — | 48.4% | -40.5% | 0.00 | 398.9% | ||
| Xenon Pharmaceuticals Inc | Biotechnology | $33.49 | $6.20B | — | — | — | — | — | -44.0% | 0.00 | -25.3% | ||
| Kiniksa Pharmaceuticals International PLC | Biotechnology | $79.10 | $6.13B | 76.0 | 3.0% | 58.9% | 2297.1% | 89.8% | 13.7% | 0.00 | 90.5% | ||
| Rhythm Pharmaceuticals Inc | Biotechnology | $88.23 | $5.93B | — | — | 53.5% | — | 70.9% | -56.6% | 0.49 | -19.5% | ||
| Kodiak Sciences Inc | Biotechnology | $91.35 | $5.74B | — | — | — | — | — | -273.2% | 0.00 | 206.7% | ||
| Immunovant Inc | Biotechnology | $27.62 | $5.70B | — | — | — | — | — | -69.6% | 0.00 | 5.2% | ||
| CG ONCOLOGY INC | Biotechnology | $59.85 | $5.31B | — | — | 1030.3% | — | -85.2% | -25.1% | 0.00 | 44.1% | ||
| Grail Inc | Biotechnology | $117.81 | $5.26B | — | — | 23.1% | — | 49.7% | -15.9% | 0.00 | 37.6% |
Data as of Oct 20, 2026
Methodology
Filter: industry = Biotechnology (Finnhub string). Sort: market cap (descending). Industry labels come from vendor classification and may change after corporate actions.
Biotechnology Stocks by Market Cap FAQs
Industry tags follow Finnhub’s classification on each ticker. Some hybrid pharma/biotech names may appear in adjacent categories on other platforms.
Size ordering helps compare established biotech platforms with smaller clinical-stage firms. It does not rank scientific merit or pipeline probability.
Open any ticker for charts, filings, AI SEC summaries, and scenario tools on Chartloom, then cross-check with primary sources.